Analyst Reco. Edwards Lifesciences Corporation Börse Stuttgart

Equities

EWL

US28176E1082

Real-time Estimate Tradegate Other stock markets 10:15:01 01/07/2024 BST			5-day change	1st Jan Change
85.81 ^EUR	-1.38%		+2.55%	+25.59%

06-20	Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing	MT
06-17	Edwards Lifesciences Corporation Announces Executive Changes	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing	06-20	MT
Wolfe Research Adjusts Price Target on Edwards Lifesciences to $70 From $75	06-17	MT
Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98	05-22	MT
Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86	05-14	MT
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing	05-13	MT
Barclays Adjusts Edwards Lifesciences Price Target to $101 From $100	05-07	MT
Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing	05-01	MT
Edwards Lifesciences Insider Sold Shares Worth $622,062, According to a Recent SEC Filing	04-30	MT
Bernstein Adjusts Price Target on Edwards Lifesciences to $73 From $72	04-29	MT
Evercore ISI Adjusts Price Target on Edwards Lifesciences to $89 From $92	04-26	MT
Stifel Adjusts Price Target on Edwards Lifesciences to $85 From $83	04-26	MT
Wells Fargo Adjusts Price Target on Edwards Lifesciences to $99 From $94	04-26	MT
UBS Adjusts Edwards Lifesciences Price Target to $95 From $92, Maintains Neutral Rating	04-26	MT
Piper Sandler Adjusts Price Target on Edwards Lifesciences to $88 From $85	04-26	MT
Canaccord Genuity Trims Price Target on Edwards Lifesciences to $85 From $86	04-26	MT
Baird Adjusts Edwards Lifesciences Price Target to $102 From $100	04-17	MT
Leerink Partners Adjusts Edwards Lifesciences' Price Target to $93 From $96, Keeps Market Perform Rating	04-17	MT
ANALYST RECOMMENDATIONS : AMD, Colgate, Fair Isaac, Tyson Foods, AstraZeneca	04-16
Zacks Investment Research Adjusts Price Target on Edwards Lifesciences to $95 From $97	04-15	MT
Truist Securities Adjusts Edwards Lifesciences Price Target to $105 From $97, Buy Rating Kept	04-15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Edwards Lifesciences Corporation: The story continues

April 23, 2024 at 04:25 pm